Akari Therapeutics, Plc (AKTX)
NASDAQ·Healthcare·Biotechnology
$7.51
+1.90%
Mkt Cap $4.49K
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$24.75
Range $19.50 – $30.00
Implied Upside
+229.6%
Consensus $24.75 vs current $7.51
NASDAQ·Healthcare·Biotechnology
$7.51
+1.90%
Mkt Cap $4.49K
No recent rating data.
Price Target (3 analysts)
$24.75
Range $19.50 – $30.00
+229.6%
Consensus $24.75 vs current $7.51